Advertisement

International Journal of Hematology

, Volume 109, Issue 4, pp 371–376 | Cite as

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL)

  • Motoko YamaguchiEmail author
  • Ritsuro Suzuki
Guide Line
  • 84 Downloads

Overview

The 2017 WHO Classification lists three entities under natural killer (NK) cell neoplasms: extranodal NK/T-cell lymphoma, nasal type (ENKL); aggressive NK-cell leukemia (ANKL); and chronic lymphoproliferative disorders of NK cells (CLPD-NK) [1]. All entities are rare, but the incidence of ANKL is less than one-seventh that of ENKL [2], therefore, there is little evidence regarding its treatment. Consequently, this chapter only covers ENKL.

ENKL is almost always derived from NK cells, but a small number of cases that originate in or around the nasal cavity (hereafter collectively referred to as nasal ENKL) are considered to be lymphomas derived from T cells. As it is not possible to differentiate between the NK- and T-cell types with current histopathological methods, which use formalin-fixed paraffin-embedded material, the entity is described as NK/T-cell lymphoma. However, as it is possible to differentiate between the NK- and T-cell types with flow cytometry or genetic...

Notes

Copyright information

© Japanese Society of Hematology 2019

Authors and Affiliations

  1. 1.Department of Hematology and OncologyMie University Graduate School of MedicineTsuJapan
  2. 2.Shimane University Hospital Innovative Cancer CenterIzumoJapan

Personalised recommendations